Guardian Pharmacy Services Inc. (NYSE: GRDN), a healthcare company, surged after reporting better-than-expected earnings. The $1.98 billion company broke decisively higher, catching the attention of traders and investors. The breakout may signal a larger move or just a short-term reaction to strong quarterly numbers.

Guardian Pharmacy Services specializes in long-term care pharmacy services, supporting residents in various facilities. With a network of over 53 pharmacies across 38 states, the company aims to become a leader in the industry. Its tech-driven approach focuses on improving medication efficiency and patient outcomes.

For Q3, Guardian reported revenue of $377 million, exceeding analyst estimates. The company raised its full-year guidance, expecting revenue of $1.43 billion to $1.45 billion and adjusted EBITDA between $104 million and $106 million. Institutional interest in the stock has been growing, while insider selling remains a notable trend.

Despite limited analyst coverage, Guardian Pharmacy Services is gaining recognition in the healthcare sector. Strong performance and raised guidance hint at potential growth. Maintaining support above $30 will be crucial for confirming the breakout and sustaining momentum in the stock.

Read more at Nasdaq: Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast